
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is facing challenges in the Chinese market, but overall performance is meeting expectations. The company is currently undervalued and has a Buy rating and a target price of $80. The company's diverse geographic sales and strong recurring revenue sources make it a stable investment for potential growth, particularly with the recent creation of the Advanced Imaging Solutions segment and overall potential for growth in the medical technology industry.
Bears say
GE HealthCare Techs is facing challenges in its key segments due to increased competition and slow uptake of recent M&A. Tariff pressures are also impacting its margins and could worsen in the future. The company's reliance on recurring revenue may not be able to offset these issues, leading to subdued financial performance in the near term.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares